Challenges in the diagnosis of arrhythmogenic cardiomyopathy in an adolescent: Case report

Arrhythmogenic cardiomyopathy/right ventricular dysplasia is a rarely diagnosed hereditary cardiomyopathy that seldom debuts in the prepubertal period. Therefore, its diagnosis at this ages certain difficulties. We present a clinical case of this disease, which we have been observing for 6 years. The first symptoms of the disease in a thirteen years old teenager were ventricular premature beats that detected during a routine electrocardiographic examination. The presence of deep negative T waves in leads V1–V3 on the ECG, the presence of stress induced of polymorphic ventricular tachycardia, the appearance of additional markers of electrical instability of the myocardium during Holter monitoring (heart rate turbulence, microvolt alternans) and ventricular late potentials made it possible to suspect and then confirm a rare cardiomyopathy – arrhythmogenic cardiomyopathy during an MRI examination of the heart. The antiarrhythmic therapy allowed stabilizing the patient’s condition. However, at the age of 18, the disease progressed with inadequate intake of drugs, episodes of loss of consciousness appeared, and a cardioverter defibrillator was implanted in the patient. The presented case of observation of a patient with cardiomyopathy, rare for the pediatric population, with a progressive unfavorable course of the disease, the use of modern diagnostic methods made it possible to identify the unfavorable nature of arrhythmia, quickly make a diagnosis and prescribe therapy that prevented the development of syncopal episodes in childhood.

1. Corrado D, Thiene G, Bauce B, Calore C, Cipriani A, De Lazzari M et al. The “Padua classification” of cardiomyopathies: Combining pathobiological basis and morpho-functional remodeling. Int J Cardiol. 2025;418:132571. https://doi.org/10.1016/j.ijcard.2024.132571.

2. Corrado D, Basso C, Judge DP. Arrhythmogenic Cardiomyopathy. Circ Res. 2017;121(7):784–802. https://doi.org/10.1161/CIRCRESAHA.117.309345.

3. Groeneweg JA, van der Heijden JF, Dooijes D, van Veen TA, van Tintelen JP, Hauer RN. Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management. Neth Heart J. 2014;22(7-8):316–325. https://doi.org/10.1007/s12471-014-0563-7.

4. Haugaa KH, Haland TF, Leren IS, Saberniak J, Edvardsen T. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2016;18(7):965–972. https://doi.org/10.1093/europace/euv340.

5. Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, Lazzari M et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020;319:106–114. https://doi.org/10.1016/j.ijcard.2020.06.005.

6. Corrado D, van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, Asimaki A et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41(14):1414–1429. https://doi.org/10.1093/eurheartj/ehz669.

7. Makarov L, Komoliatova V. Microvolt T-wave alternans during Holter monitoring in children and adolescents. Ann Noninvasive Electrocardiol. 2010;15(2):138–144. https://doi.org/10.1111/j.1542-474X.2010.00354.x.

8. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806–814. https://doi.org/10.1093/eurheartj/ehq025.

9. Corrado D, Anastasakis A, Basso C, Bauce B, Blomström-Lundqvist C, Bucciarelli-Ducci C et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiol. 2024;395:131447. https://doi.org/10.1016/j.ijcard.2023.131447.

10. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289–1300. https://doi.org/10.1016/S0140-6736(09)60256-7.

11. Quarta G, Muir A, Pantazis A, Syrris P, Gehmlich K, Garcia-Pavia P et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123(23):2701–2709. https://doi.org/10.1161/CIRCULATIONAHA.110.976936.

12. Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C et al. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015;8(3):437–446. https://doi.org/10.1161/CIRCGENETICS.114.001003.

13. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62(14):1290–1297. https://doi.org/10.1016/j.jacc.2013.06.033.

14. Saberniak J, Hasselberg NE, Borgquist R, Platonov PG, Sarvari SI, Smith HJ et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail. 2014;16(12):1337–1344. https://doi.org/10.1002/ejhf.181.

15. Fujino M, Miyazaki A, Furukawa O, Somura J, Yoshida Y, Hayama Y et al. Electrocardiographic features of arrhythmogenic right ventricular cardiomyopathy in school-aged children. Heart Vessels. 2021;36(6):863–873. https://doi.org/10.1007/s00380-020-01754-2.

16. Etoom Y, Govindapillai S, Hamilton R, Manlhiot C, Yoo SJ, Farhan M et al. Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents. J Am Coll Cardiol. 2015;65(10):987–995. https://doi.org/10.1016/j.jacc.2014.12.041.

17. Te Riele ASJM, James CA, Sawant AC, Bhonsale A, Groeneweg JA, Mast TP et al. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With AdultOnset Disease. JACC Clin Electrophysiol. 2015;1(6):551–560. https://doi.org/10.1016/j.jacep.2015.08.004.

18. Alekseeva DYu, Kofeynikova OА, Marapov DI, Vasichkina ES. Electrocardiographic parameters and features of ventricular arrhythmias in various arrhythmogenic cardiomyopathy forms in the pediatric population: a systematic review and meta-analysis. Russian Journal of Cardiology. 2022;27(3S):91–100. (In Russ.) https://doi.org/10.15829/1560-4071-2022-5147.

19. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–2867. https://doi.org/10.1093/eurheartj/ehv316.

20. Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner DV, Hohnloser SH et al. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility – consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol. 2011;58(13):1309–1324. https://doi.org/10.1016/j.jacc.2011.06.029.

21. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz et al. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol. 2008;52(17):1353–1365. https://doi.org/10.1016/j.jacc.2008.07.041.

22. Kofeynikova OA, Alexeeva DYu, Characterova EV, Kostareva AA, Vasichkina ES. Arrhythmogenic Cardiomyopathy in 8-Year-Old Girl: Clinical Case. Difficult Path to Diagnosis. Pediatric Pharmacology. 2023;20(6):574–579. (In Russ.) https://doi.org/10.15690/pf.v20i6.2664.